TARDIVE DYSKINESIA
Clinical trials for TARDIVE DYSKINESIA explained in plain language.
Never miss a new study
Get alerted when new TARDIVE DYSKINESIA trials appear
Sign up with your email to follow new studies for TARDIVE DYSKINESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study offers hope for persistent movement disorder
Disease control Recruiting nowThis study tests whether valbenazine can help people with tardive dyskinesia (uncontrollable movements) who still have symptoms while taking or after stopping another drug. About 50 adults with schizophrenia, bipolar disorder, or major depression will take valbenazine for 24 week…
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE4 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
New drug aims to quiet uncontrollable movements in tardive dyskinesia
Symptom relief Recruiting nowThis study tests an experimental drug, NBI-1065890, against a placebo in 100 adults with tardive dyskinesia (uncontrollable movements) caused by psychiatric medications. Participants must have schizophrenia, bipolar disorder, or similar conditions. The main goal is to see if the …
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 26, 2026 05:01 UTC
-
Brain zaps may tame Drug-Induced movement disorder
Symptom relief Recruiting nowThis study tests whether a precise, non-invasive brain stimulation technique called rTMS can reduce involuntary muscle spasms in people with tardive dyskinesia, a condition caused by long-term use of certain medications. About 62 adults will receive either real or sham stimulatio…
Matched conditions: TARDIVE DYSKINESIA
Phase: NA • Sponsor: Peking University Sixth Hospital • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC